Paari Dominic
Clinical Cardiac Electrophysiology · Iowa City, IANPI 1134328958
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (31.0%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Boston Scientific at 42.8% of the total. 2025 is the largest year on record at $45,936, more than ten times the $3,661 reported in 2019. Among clinical cardiac electrophysiology clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 657 payments — averaging $126.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$35K
- Biosense Webster, Inc.$28K
- Abbott$8K
- Medtronic$2K
- Atricure, Inc.$1K
- Medical Device Business Services, Inc.$1K
- plus $7K from 26 others
Across 48 payments — averaging $1901.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$62K
- Medical Device Business Services, Inc.$18K
- Abbott$11K
What the payments were for
- Consulting fees$18,42522%
- Speaking & faculty fees$23,86629%
- Travel & lodging$14,82018%
- Food & beverage$25,67931%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 165 | $35,454 |
| Biosense Webster, Inc. | 136 | $28,143 |
| Abbott | 109 | $7,972 |
| Medtronic(2 entities) | 49 | $1,725 |
| Atricure, Inc. | 21 | $1,477 |
| Medical Device Business Services, Inc. | 6 | $1,341 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 35 | $966 |
| ZOLL Respicardia, Inc. | 6 | $915 |
| Impulse Dynamics (USA) Inc. | 16 | $870 |
| Itamar Medical Inc | 5 | $728 |
| Cardiva Medical, Inc. | 11 | $576 |
| Abiomed | 10 | $490 |
| Philips North America LLC | 6 | $485 |
| Pfizer | 22 | $289 |
| Biotronik Inc. | 5 | $278 |
| Elutia, Inc. | 16 | $273 |
| Johnson & Johnson | 8 | $144 |
| AstraZeneca | 7 | $96 |
| Inspire Medical Systems, Inc. | 1 | $85 |
| Preventice Services, LLC | 1 | $82 |
| Sanofi-aventis U.S. LLC | 4 | $68 |
| E.r. Squibb & Sons, L.L.C. | 4 | $61 |
| Regeneron Healthcare Solutions, Inc. | 3 | $38 |
| Irhythm Technologies, Inc. | 1 | $37 |
| Volta Medical Inc | 1 | $37 |
| Novartis | 2 | $32 |
| Bardy Diagnostics, Inc. | 2 | $28 |
| Portola Pharmaceuticals, LLC | 1 | $26 |
| Shockwave Medical, Inc | 1 | $25 |
| Penumbra, Inc. | 1 | $19 |
| Merck | 1 | $15 |
| Terumo Medical Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$25,320
- INGEVITY$9,750
- GENERAL EP$8,144
- AVEIR$3,043
- Farapulse$2,230
- AGILIS$1,614
- Watchman$1,261
- OPTIMIZER$1,107
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$722
- remede System$669
- GENERAL BRADY$600
- WatchPATONE$563
- ENSITE$418
- GENERAL - THERAPIES$412
- Cardiva VASCADE MVP VVCS 6-12F$343
- LINQ II$318
- Impella$289
- (9520) IGT Devices Undivided$250
- LUX-Dx Insertable Cardiac Monitor$246
- Rhythmia Mapping System$239
How this compares
$82,790 in reported general payments places this provider in the 90th percentile of 42 clinical cardiac electrophysiology providers in Iowa.
See all clinical cardiac electrophysiology providers in Iowa →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 105 | $79,431 |
| XareltoRivaroxaban | 18 | $16,275 |
| Dofetilide | 17 | $1,881 |
| Amiodarone Hcl | 87 | $1,578 |
| Flecainide Acetate | 17 | $1,339 |
| SotalolSotalol Hcl | 53 | $443 |
| Metoprolol Succinate | 41 | $412 |
| ClopidogrelClopidogrel Bisulfate | 30 | $282 |
| Metoprolol Tartrate | 22 | $62 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $289 | $79,431105 claims |
| Johnson & JohnsonXarelto | $144 | $16,27518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 42 clinical cardiac electrophysiology providers in Iowa.
Other clinical cardiac electrophysiology in Iowa City
- Steven MickelsenIowa City$2.4M
- Peter FarjoIowa City$72K
- Oluwaseun AdeolaIowa City$49K
- Sean ByrnesIowa City$36K
- Edward PowersIowa City$33K
- Samuel JohnstonIowa City$23K
- Denice Hodgson ZingmanIowa City$17K
- Troy RhodesIowa City$15K
- Hina AminIowa City$14K
- David HamonIowa City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.